Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02471716
Title Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Acronym FPA008-002
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Five Prime Therapeutics, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NLD | GBR | FRA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Sarcoma Oncology Research Center LLC Santa Monica California 90403 United States Details
Stanford Medicine Stanford California 94301-5821 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
The University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
Institut Bergonie- CRLCC de Bordeaux et du Sud-Ouest Bordeaux 33076 France Details
Centre Léon Bérard Lyon 69008 France Details
Seoul National University Hospital Seoul Jongno-gu 110-744 Korea, Republic of Details
Leiden University Medical Center Leiden 2333 ZA Netherlands Details
Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie Warsaw 02-781 Poland Details
University Hospitals Birmingham NHS Foundation Trust Birmingham B15 2TH United Kingdom Details
Oxford University Hospital NHS Trust Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field